梅斯医学

订阅

MedSci主页 / 所有栏目 / 梅斯医学

凯乘资本荣获企名片2021年度榜单 “医疗健康领域更佳财务顾问 TOP2”、“更佳财务顾问-活跃榜 TOP10”

2022-01-18 网络 网络

关注

凯乘资本荣获企名片2021年度榜单 “医疗健康领域最佳财务顾问 TOP2”、“最佳财务顾问-活跃榜 TOP10”

2022年1月17日，中国领先的金融大数据平台企名片重磅发布“ 2021 中国股权投资年度榜单”，其中凯乘资本（WinX Capital ）凭借出色的业绩和极佳的声誉，荣获“医疗健康领域最佳财务顾问 TOP2”；以及“最佳财务顾问-活跃榜 TOP10”，也是该细分榜单TOP10中唯一一家专注医疗大健康领域的精品投行。

2018年起，企名片创服团队已连续4年发布中国股权投资年度排名，依托企名片强大的大数据优势，秉承着数据为准、公平公正的态度，通过调研问卷、集合走访和电话回访等多种方式，综合对结构各方面进行严格考核，最后评选出获得了投资机构以及财务顾问机构的一致肯定的榜单。

 

企名片数据显示，2021年一级市场的投资事件总数超过16000起，比2020年整体上升了约30%，投资金额数超过14000亿人民币，超越2018年，刷新了年度投资金额总数记录。同时，2021年公司IPO上市事件数和总融资金额也刷新了2017年保持的记录，总上市事件数超过670起，总融资金额接近10000亿人民币。其中生产制造、企业服务、医疗健康成为2021年最受投资者喜爱的赛道，不论是整体投资事件数还是融资金额都远超其他赛道。

凯乘资本（WinX Capital ）是中国领先的大健康领域投资银行。创始团队有5位是清华大学五道口金融学院全球金融博士，一线团队有平均10+年管理及投资并购经验，累计投资并购金额超过300亿元。总部位于北京及上海，覆盖3000余家活跃投资机构及产业集团。2020、2021年连续被36氪评为“WISE2020/2021中国最具成长力新型投行 Top 5”，企名科技&新声创服“2020年度医疗健康领域最佳财务顾问机构 Top 4”，“2021年度医疗健康领域最佳财务顾问机构 Top 2”。

 

凯乘资本在近一年多时间，接连完成了五十余个重磅项目、明星项目的融资/并购，包括：康乐卫士（Pre-IPO轮10.15亿元）、海创药业（C轮10亿元）、华昊中天（Pre-IPO轮8.9亿元）、轩竹生物（B轮超6亿元）、合源生物（B轮4.5亿元）、润生药业（C轮系列4亿元）、绿竹生物（B轮3.5亿元、B+轮数亿元）、同源康（C轮3.3亿元）、先通医药（D+轮3.2亿元）、维眸生物（D轮3亿元）、启愈生物（B轮近2亿元）、安渡生物（B轮3000万美金、B+轮6000万美金）、华健未来（数亿元B+轮）、好心情（2亿元C轮）、畅溪制药（C轮近2亿元）、华芯医疗（数亿元A轮、数亿元A+轮）、励楷科技（B轮数亿元、B+轮数亿元）、奥素博新、阿吉安、汇健科技、博恩锐尔、长木谷（A+ /B轮）、燧坤智能、图湃影像、万洁天元、美立刻、安颂科技、聚融医疗、门罗生物、百因诺等几十个融资额过亿的大额交易，迅速占领了行业绝对领先地位。

 

栉风沐雨砥砺行，春华秋实满庭芳。凯乘资本衷心感谢各位企业家朋友和投资人朋友、媒体朋友！感恩信任，不负所托。未来我们将继续以“帮助客户找到最合适的投资与发展解决方案”为使命，秉持“长期陪伴、携手同行、追求多赢”的价值观和理念，乘风破浪，行稳致远；与优秀的企业家客户一同成长，为投资机构持续打造可观回报。

版权声明：
本网站所有内容来源注明为“梅斯医学”或“MedSci原创”的文字、图片和音视频资料，版权均属于梅斯医学所有。非经授权，任何媒体、网站或个人不得转载，授权转载时须注明来源为“梅斯医学”。其它来源的文章系转载文章，或“梅斯号”自媒体发布的文章，仅系出于传递更多信息之目的，本站仅负责审核内容合规，其内容不代表本站立场，本站不负责内容的准确性和版权。如果存在侵权、或不希望被转载的媒体或个人可与我们联系，我们将立即进行删除处理。
在此留言
评论区 (4)
#插入话题
  1. [GetPortalCommentsPageByObjectIdResponse(id=1719331, encodeId=dde71e19331d1, content=<a href='/topic/show?id=12b792553da' target=_blank style='color:#2F92EE;'>#资本#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=28, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=92553, encryptionId=12b792553da, topicName=资本)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ef5032698226, createdName=kord1993, createdTime=Fri Apr 15 04:49:44 CST 2022, time=2022-04-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1649878, encodeId=90ab16498e819, content=<a href='/topic/show?id=f1e41e642cd' target=_blank style='color:#2F92EE;'>#TOP10#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=28, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=17642, encryptionId=f1e41e642cd, topicName=TOP10)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=bb7b23929551, createdName=respect, createdTime=Wed Jun 15 15:49:44 CST 2022, time=2022-06-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1705038, encodeId=16721e05038fd, content=<a href='/topic/show?id=0d5c6293544' target=_blank style='color:#2F92EE;'>#榜单#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=57, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=62935, encryptionId=0d5c6293544, topicName=榜单)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=0d7a30920910, createdName=gwc393, createdTime=Wed Dec 14 22:49:44 CST 2022, time=2022-12-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2052493, encodeId=124b2052493e4, content=<a href='/topic/show?id=271f2e96486' target=_blank style='color:#2F92EE;'>#健康领域#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=32, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=27964, encryptionId=271f2e96486, topicName=健康领域)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=d4b7363, createdName=pandamao2010, createdTime=Mon Jun 20 06:49:44 CST 2022, time=2022-06-20, status=1, ipAttribution=)]
    2022-04-15 kord1993

    #资本#

    0

  2. [GetPortalCommentsPageByObjectIdResponse(id=1719331, encodeId=dde71e19331d1, content=<a href='/topic/show?id=12b792553da' target=_blank style='color:#2F92EE;'>#资本#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=28, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=92553, encryptionId=12b792553da, topicName=资本)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ef5032698226, createdName=kord1993, createdTime=Fri Apr 15 04:49:44 CST 2022, time=2022-04-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1649878, encodeId=90ab16498e819, content=<a href='/topic/show?id=f1e41e642cd' target=_blank style='color:#2F92EE;'>#TOP10#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=28, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=17642, encryptionId=f1e41e642cd, topicName=TOP10)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=bb7b23929551, createdName=respect, createdTime=Wed Jun 15 15:49:44 CST 2022, time=2022-06-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1705038, encodeId=16721e05038fd, content=<a href='/topic/show?id=0d5c6293544' target=_blank style='color:#2F92EE;'>#榜单#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=57, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=62935, encryptionId=0d5c6293544, topicName=榜单)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=0d7a30920910, createdName=gwc393, createdTime=Wed Dec 14 22:49:44 CST 2022, time=2022-12-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2052493, encodeId=124b2052493e4, content=<a href='/topic/show?id=271f2e96486' target=_blank style='color:#2F92EE;'>#健康领域#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=32, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=27964, encryptionId=271f2e96486, topicName=健康领域)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=d4b7363, createdName=pandamao2010, createdTime=Mon Jun 20 06:49:44 CST 2022, time=2022-06-20, status=1, ipAttribution=)]
    2022-06-15 respect

    #TOP10#

    0

  3. [GetPortalCommentsPageByObjectIdResponse(id=1719331, encodeId=dde71e19331d1, content=<a href='/topic/show?id=12b792553da' target=_blank style='color:#2F92EE;'>#资本#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=28, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=92553, encryptionId=12b792553da, topicName=资本)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ef5032698226, createdName=kord1993, createdTime=Fri Apr 15 04:49:44 CST 2022, time=2022-04-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1649878, encodeId=90ab16498e819, content=<a href='/topic/show?id=f1e41e642cd' target=_blank style='color:#2F92EE;'>#TOP10#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=28, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=17642, encryptionId=f1e41e642cd, topicName=TOP10)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=bb7b23929551, createdName=respect, createdTime=Wed Jun 15 15:49:44 CST 2022, time=2022-06-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1705038, encodeId=16721e05038fd, content=<a href='/topic/show?id=0d5c6293544' target=_blank style='color:#2F92EE;'>#榜单#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=57, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=62935, encryptionId=0d5c6293544, topicName=榜单)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=0d7a30920910, createdName=gwc393, createdTime=Wed Dec 14 22:49:44 CST 2022, time=2022-12-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2052493, encodeId=124b2052493e4, content=<a href='/topic/show?id=271f2e96486' target=_blank style='color:#2F92EE;'>#健康领域#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=32, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=27964, encryptionId=271f2e96486, topicName=健康领域)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=d4b7363, createdName=pandamao2010, createdTime=Mon Jun 20 06:49:44 CST 2022, time=2022-06-20, status=1, ipAttribution=)]
    2022-12-14 gwc393

    #榜单#

    0

  4. [GetPortalCommentsPageByObjectIdResponse(id=1719331, encodeId=dde71e19331d1, content=<a href='/topic/show?id=12b792553da' target=_blank style='color:#2F92EE;'>#资本#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=28, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=92553, encryptionId=12b792553da, topicName=资本)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ef5032698226, createdName=kord1993, createdTime=Fri Apr 15 04:49:44 CST 2022, time=2022-04-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1649878, encodeId=90ab16498e819, content=<a href='/topic/show?id=f1e41e642cd' target=_blank style='color:#2F92EE;'>#TOP10#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=28, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=17642, encryptionId=f1e41e642cd, topicName=TOP10)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=bb7b23929551, createdName=respect, createdTime=Wed Jun 15 15:49:44 CST 2022, time=2022-06-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1705038, encodeId=16721e05038fd, content=<a href='/topic/show?id=0d5c6293544' target=_blank style='color:#2F92EE;'>#榜单#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=57, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=62935, encryptionId=0d5c6293544, topicName=榜单)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=0d7a30920910, createdName=gwc393, createdTime=Wed Dec 14 22:49:44 CST 2022, time=2022-12-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2052493, encodeId=124b2052493e4, content=<a href='/topic/show?id=271f2e96486' target=_blank style='color:#2F92EE;'>#健康领域#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=32, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=27964, encryptionId=271f2e96486, topicName=健康领域)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=d4b7363, createdName=pandamao2010, createdTime=Mon Jun 20 06:49:44 CST 2022, time=2022-06-20, status=1, ipAttribution=)]
    2022-06-20 pandamao2010

    #健康领域#

    0